BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• Press Releases

  Silexion Therapeutics Unveils Innovative Expanded Development Plan for SIL204 Based on Recent Groundbreaking Preclinical Data

  March 28, 2025

   · 

  5 min read
• Press Releases

  FDA Grants Marketing Authorization of First Home Test for Chlamydia, Gonorrhea and Trichomoniasis

  March 28, 2025

   · 

  4 min read
• Press Releases

  Visby Medical Receives Landmark FDA De Novo Authorization for First-Ever OTC PCR Test for Sexual Health

  March 28, 2025

   · 

  3 min read
• Press Releases

  Solaxa Announces Phase 3 Clinical Trial for Spinocerebellar Ataxia Type 27B

  March 28, 2025

   · 

  1 min read
• Press Releases

  FDA approves Novartis radioligand therapy Pluvicto® for earlier use before chemotherapy in PSMA-positive metastatic castration-resistant prostate cancer

  March 28, 2025

   · 

  13 min read
• Press Releases

  HCW Biologics Reports Fourth Quarter and Fiscal Year 2024 Business Highlights and Financial Results

  March 28, 2025

   · 

  14 min read
• Press Releases

  Marvel Biosciences Announces Private Placement

  March 28, 2025

   · 

  6 min read
• Press Releases

  Urteste plans to start clinical trials for its pancreatic cancer test in Europe in Q3 2025

  March 28, 2025

   · 

  4 min read
• Press Releases

  GE HealthCare announces cash dividend for first quarter of 2025

  March 28, 2025

   · 

  1 min read
• Press Releases

  Bio-Thera and Dr. Reddy’s Execute Exclusive Commercialization Agreement for BAT2206, a Proposed Stelara® Biosimilar, and BAT2506, a Proposed Simponi® Biosimilar, for Southeast Asia

  March 28, 2025

   · 

  8 min read